Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Signalling pathways of the TNF superfamily: a double-edged sword.

Aggarwal BB.

Nat Rev Immunol. 2003 Sep;3(9):745-56. Review.

PMID:
12949498
2.

TNF ligands and receptors in autoimmunity: an update.

Mackay F, Kalled SL.

Curr Opin Immunol. 2002 Dec;14(6):783-90. Review.

PMID:
12413530
3.

Regulation of proliferation, survival and apoptosis by members of the TNF superfamily.

Gaur U, Aggarwal BB.

Biochem Pharmacol. 2003 Oct 15;66(8):1403-8. Review.

PMID:
14555214
4.

Tumour necrosis factor and lymphotoxin: molecular aspects and role in tissue-specific autoimmunity.

Körner H, Sedgwick JD.

Immunol Cell Biol. 1996 Oct;74(5):465-72. Review.

5.

The role of TNF and its family members in inflammation and cancer: lessons from gene deletion.

Aggarwal BB, Shishodia S, Ashikawa K, Bharti AC.

Curr Drug Targets Inflamm Allergy. 2002 Dec;1(4):327-41. Review.

PMID:
14561180
6.

Lymphotoxin/light, lymphoid microenvironments and autoimmune disease.

Gommerman JL, Browning JL.

Nat Rev Immunol. 2003 Aug;3(8):642-55. Review.

PMID:
12974479
7.

The TNF-TNF receptor system.

Hehlgans T, Männel DN.

Biol Chem. 2002 Oct;383(10):1581-5. Review.

PMID:
12452434
8.
9.

What does tumour necrosis factor excess do to the immune system long term?

Clark J, Vagenas P, Panesar M, Cope AP.

Ann Rheum Dis. 2005 Nov;64 Suppl 4:iv70-6. Review.

10.

Biological functions of tumor necrosis factor cytokines and their receptors.

Pfeffer K.

Cytokine Growth Factor Rev. 2003 Jun-Aug;14(3-4):185-91. Review.

PMID:
12787558
11.

Tumor necrosis factor, lymphotoxin and cancer.

Drutskaya MS, Efimov GA, Kruglov AA, Kuprash DV, Nedospasov SA.

IUBMB Life. 2010 Apr;62(4):283-9. doi: 10.1002/iub.309. Review.

12.

Network communications: lymphotoxins, LIGHT, and TNF.

Ware CF.

Annu Rev Immunol. 2005;23:787-819. Review.

PMID:
15771586
13.

TNF-mediated inflammatory disease.

Bradley JR.

J Pathol. 2008 Jan;214(2):149-60. Review.

PMID:
18161752
14.

The uncertain glory of APRIL.

Medema JP, Planelles-Carazo L, Hardenberg G, Hahne M.

Cell Death Differ. 2003 Oct;10(10):1121-5. Review.

15.

Lymphotoxin alpha 1 beta 2: a critical mediator in V alpha 14i NKT cell differentiation.

Franki AS, Van Beneden K, Dewint P, Meeus I, Veys E, Deforce D, Elewaut D.

Mol Immunol. 2005 Feb;42(4):413-7. Review.

PMID:
15607792
16.

An APRIL to remember: novel TNF ligands as therapeutic targets.

Dillon SR, Gross JA, Ansell SM, Novak AJ.

Nat Rev Drug Discov. 2006 Mar;5(3):235-46. Review.

PMID:
16474316
17.

[The role of BAFF in autoimmune diseases].

Matsushita T, Sato S.

Nihon Rinsho Meneki Gakkai Kaishi. 2005 Oct;28(5):333-42. Review. Japanese.

18.

[Biology of tumor necrosis factor type alpha (TNF-alpha)].

Korobowicz A.

Pol Merkur Lekarski. 2006 Oct;21(124):358-61. Review. Polish.

PMID:
17205778
19.

Looking beyond death: a morphogenetic role for the TNF signalling pathway.

Mathew SJ, Haubert D, Krönke M, Leptin M.

J Cell Sci. 2009 Jun 15;122(Pt 12):1939-46. doi: 10.1242/jcs.044487. Review.

20.

Emerging applications of the tumor necrosis factor family of ligands and receptors in cancer therapy.

Younes A, Kadin ME.

J Clin Oncol. 2003 Sep 15;21(18):3526-34. Review.

PMID:
12972530

Supplemental Content

Support Center